Sopharma AD Statistics
Total Valuation
Sopharma AD has a market cap or net worth of BGN 944.66 million. The enterprise value is 1.34 billion.
Market Cap | 944.66M |
Enterprise Value | 1.34B |
Important Dates
The next estimated earnings date is Thursday, January 30, 2025.
Earnings Date | Jan 30, 2025 |
Ex-Dividend Date | Nov 7, 2024 |
Share Statistics
Sopharma AD has 165.73 million shares outstanding. The number of shares has increased by 35.29% in one year.
Current Share Class | n/a |
Shares Outstanding | 165.73M |
Shares Change (YoY) | +35.29% |
Shares Change (QoQ) | +4.23% |
Owned by Insiders (%) | 9.17% |
Owned by Institutions (%) | 4.89% |
Float | 40.65M |
Valuation Ratios
The trailing PE ratio is 12.32.
PE Ratio | 12.32 |
Forward PE | n/a |
PS Ratio | 0.45 |
PB Ratio | 1.19 |
P/TBV Ratio | 1.30 |
P/FCF Ratio | 8.51 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.57, with an EV/FCF ratio of 12.07.
EV / Earnings | 16.35 |
EV / Sales | 0.65 |
EV / EBITDA | 8.57 |
EV / EBIT | 13.11 |
EV / FCF | 12.07 |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.48.
Current Ratio | 1.43 |
Quick Ratio | 0.73 |
Debt / Equity | 0.48 |
Debt / EBITDA | 3.02 |
Debt / FCF | 3.67 |
Interest Coverage | 6.60 |
Financial Efficiency
Return on equity (ROE) is 10.95% and return on invested capital (ROIC) is 4.23%.
Return on Equity (ROE) | 10.95% |
Return on Assets (ROA) | 3.35% |
Return on Capital (ROIC) | 4.23% |
Revenue Per Employee | 434,506 |
Profits Per Employee | 17,350 |
Employee Count | 4,721 |
Asset Turnover | 1.36 |
Inventory Turnover | 4.48 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.72% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -19.72% |
50-Day Moving Average | 5.83 |
200-Day Moving Average | 5.98 |
Relative Strength Index (RSI) | 46.95 |
Average Volume (20 Days) | 4,842 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sopharma AD had revenue of BGN 2.05 billion and earned 81.91 million in profits. Earnings per share was 0.46.
Revenue | 2.05B |
Gross Profit | 448.37M |
Operating Income | 80.85M |
Pretax Income | 95.97M |
Net Income | 81.91M |
EBITDA | 117.38M |
EBIT | 80.85M |
Earnings Per Share (EPS) | 0.46 |
Balance Sheet
The company has 38.10 million in cash and 407.24 million in debt, giving a net cash position of -369.14 million or -2.23 per share.
Cash & Cash Equivalents | 38.10M |
Total Debt | 407.24M |
Net Cash | -369.14M |
Net Cash Per Share | -2.23 |
Equity (Book Value) | 841.72M |
Book Value Per Share | 4.80 |
Working Capital | 249.15M |
Cash Flow
In the last 12 months, operating cash flow was 137.97 million and capital expenditures -26.98 million, giving a free cash flow of 110.99 million.
Operating Cash Flow | 137.97M |
Capital Expenditures | -26.98M |
Free Cash Flow | 110.99M |
FCF Per Share | 0.67 |
Margins
Gross margin is 21.86%, with operating and profit margins of 3.94% and 3.99%.
Gross Margin | 21.86% |
Operating Margin | 3.94% |
Pretax Margin | 4.68% |
Profit Margin | 3.99% |
EBITDA Margin | 5.72% |
EBIT Margin | 3.94% |
FCF Margin | 5.41% |
Dividends & Yields
This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 2.63%.
Dividend Per Share | 0.15 |
Dividend Yield | 2.63% |
Dividend Growth (YoY) | -89.00% |
Years of Dividend Growth | 2 |
Payout Ratio | 278.20% |
Buyback Yield | -35.29% |
Shareholder Yield | -32.65% |
Earnings Yield | 8.12% |
FCF Yield | 11.75% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Sopharma AD has an Altman Z-Score of 3.09.
Altman Z-Score | 3.09 |
Piotroski F-Score | n/a |